Latest Breaking News On - Pascal touchon - Page 18 : comparemela.com

European Commission Approves Atara s Ebvallo as First Ever Therapy for Adults and Children with EBV+ PTLD

European Commission Approves Atara s Ebvallo as First Ever Therapy for Adults and Children with EBV+ PTLD
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Pierre fabreBiotherapeutic ebvalloEric ducournauPascal touchonEuropean unionEuropean commissionMedicinal productsHuman useEuropean medicines agencyEbvallo marketing authorization application

Ebvallo™ given world s first approval of an allogeneic T-cell therapy

Ebvallo™ is the first authorised allogeneic T-cell immunotherapy and has been approved for EU patients with relapsed or refractory EBV+ PTLD.

Pierre fabrePascal touchonEuropean commissionEuropean union member statesCommittee for medicinal products human useChief executive officerMedicinal productsHuman useUnion member statesLicense agreementAuthorization application

Atara Biotherapeutics Announces $31 Million Royalty Interest Financing Agreement with HealthCare Royalty

Atara Biotherapeutics Announces $31 Million Royalty Interest Financing Agreement with HealthCare Royalty
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth san franciscoCity ofUnited kingdomSan franciscoPierre fabreEric hyllengrenAlex chapmanClarke futchPascal touchonAtara biotherapeutics incEuropean commissionExchange commissionHealthcare royalty managementSecurities exchangeCare royalty receives specified milestones

ATARA Biotherapeutics (ATRA) Enters $31M Royalty Interest Financing Agreement with HealthCare Royalty

ATARA Biotherapeutics (ATRA) Enters $31M Royalty Interest Financing Agreement with HealthCare Royalty
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Atara Biotherapeutics Ebvallo® (tabelecleucel) Receives European Commission Approval as First Ever Therapy for Adults and Children with EBV+ PTLD

/PRNewswire/ Atara Biotherapeutics, Inc. (Nasdaq: ATRA), and Pierre Fabre today announced that the European Commission (EC) has granted marketing.

Midi pyréesUnited statesPierre fabreEric hyllengrenEric ducournauLaure sgandurraPascal touchonAtara biotherapeutics incEuropean commissionEuropean unionEuropean medicines agencyCommittee for medicinal products human usePierre fabre health carePierre fabre foundationOnly approved therapyPotentially deadly cancer facing median survival